CVS Health sets November 4 results and declares a USD 0.665 dividend per CVS Health stock

Published on 10/23/2026 at 10:54 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

The payout is due November 2, 2026. CVS Health stock costs EUR 84.26 on October 23, 2026, 0.57 percent above its Xetra close.

Results and dividend dates

On October 5, 2026, CVS Health scheduled third-quarter results for November 4, 2026.
Second-quarter revenue reached USD 106.10 billion, up 7.30 percent year over year.
CVS Health stock trades at EUR 84.26 at 10:44 a.m. CEST at Lang & Schwarz on October 23, 2026, 0.57 percent above the Xetra close of October 22, 2026.
Twenty analysts rated CVS Health Buy and three rated it Hold in MarketBeat's October 19, 2026 report.

Draufsicht-Arrangement aus Aktienzertifikat, Stethoskop, Medikamenten und Finanzunterlagen auf Marmor — CVS Health Corp. Flatlay-Arrangement mit Aktienzertifikat, Stethoskop und pharmazeutischen Medikamenten, ISIN US1266501006, Illustration mit AI erstellt.

CVS Health Corp. (ISIN US1266501006) scheduled its third-quarter 2026 results for November 4, 2026, and declared a quarterly dividend of USD 0.665 per share on September 30, 2026, according to CVS Health and PR Newswire. At Lang & Schwarz, the stock was trading at EUR 84.26 on October 23, 2026 at 10:44 a.m. CEST, up 0.57 percent versus the Xetra close of October 22, 2026 at EUR 83.78.

Results provide a stronger base

On August 5, 2026, CVS Health reported second-quarter revenue of USD 106.10 billion, up 7.30 percent from the prior-year quarter, while earnings per share reached USD 2.58 against a USD 1.87 consensus estimate, MarketBeat reported on October 19, 2026. The company also set full-year 2026 earnings-per-share guidance at USD 7.90 to USD 8.10, giving the November report a clear benchmark.

On September 30, 2026, the board approved the USD 0.665 quarterly dividend, payable on November 2, 2026, to holders of record on October 22, 2026, according to PR Newswire. The payout adds an income component while the operating results remain the main test for the stock.

What does the analyst view add?

MarketBeat said on October 19, 2026, that JPMorgan raised its CVS Health target from USD 111.00 to USD 118.00 on August 12, 2026, while twenty analysts held Buy ratings and three held Hold ratings. The same report cited a consensus target of USD 107.80, but also noted pressure from medical costs and Medicare Advantage uncertainty.

When are the next dates?

CVS Health will pay the USD 0.665 dividend on November 2, 2026, and will discuss third-quarter results on November 4, 2026 at 8:00 a.m. ET, according to PR Newswire and CVS Health. Those dates should clarify whether the improved first-half performance supports the full-year guidance range.

Stock holds above the Xetra close

The euro quotation was 0.57 percent above the Xetra close of October 22, 2026. The modest daily gap keeps the scheduled results and dividend dates more important than short-term price direction.

The further course of trading is shown by the continuously updated real-time quote of CVS Health stock.